Jacob Nersting
Overview
Explore the profile of Jacob Nersting including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
737
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Pietri S, Weischendorff S, Rathe M, Frandsen T, Hasle H, Nersting J, et al.
Int J Cancer
. 2023 Jun;
153(9):1635-1642.
PMID: 37387257
Chemotherapy-induced mucositis increases the risk of blood stream infections (BSI) due to translocation of bacteria across the intestinal epithelium. Our study investigated if quantitative measures of intestinal mucositis severity, including...
2.
Nersting J, Terzic D, Hansen L, Goetze J
Clin Chem
. 2023 Feb;
69(4):313-315.
PMID: 36807507
No abstract available.
3.
Nazerai L, Willis S, Yankilevich P, Di Leo L, Maria Bosisio F, Frias A, et al.
Oncoimmunology
. 2022 Dec;
12(1):2158610.
PMID: 36545256
Immune-checkpoint inhibitors (ICI) are highly effective in reinvigorating T cells to attack cancer. Nevertheless, a large subset of patients fails to benefit from ICI, partly due to lack of the...
4.
Pedersen L, Ostergaard A, Bank V, Nersting J, Tuckuviene R, Wehner P, et al.
Pediatr Blood Cancer
. 2021 Dec;
69(7):e29508.
PMID: 34931732
Background: Socioeconomic differences in survival among children with acute lymphoblastic leukemia (ALL) have been reported in high-income countries and there is an unmet need for strategies to identify vulnerable patient...
5.
Toksvang L, Grell K, Nygaard Nielsen S, Nersting J, Murdy D, Moorman A, et al.
Leukemia
. 2021 Sep;
36(2):555-557.
PMID: 34535761
No abstract available.
6.
Grosen A, Bellaguarda E, Nersting J, Lodberg Hvas C, Liljeqvist-Soltic I, Stein A, et al.
Inflamm Bowel Dis
. 2021 Aug;
28(7):1012-1018.
PMID: 34463329
Background: Methotrexate is widely used in inflammatory diseases during the patients' reproductive years. The effect on male fertility and sperm DNA integrity is largely unknown. We evaluated sperm DNA integrity...
7.
Toksvang L, Grell K, Nersting J, Degn M, Nielsen S, Abrahamsson J, et al.
Leukemia
. 2021 Jun;
36(1):33-41.
PMID: 34175901
Methotrexate/6-mercaptopurine maintenance therapy improves acute lymphoblastic leukemia (ALL) outcome. Cytotoxicity is mediated by DNA incorporation of thioguanine nucleotides (DNA-TG). We investigated the association of DNA-TG to relapse risk in 1 ...
8.
Toksvang L, Andres-Jensen L, Rank C, Niinimaki R, Nersting J, Nygaard Nielsen S, et al.
Cancer Chemother Pharmacol
. 2021 Jun;
88(5):911-917.
PMID: 34145469
Purpose: Osteonecrosis is a burdensome treatment-related toxicity that is mostly diagnosed during or soon after 6-mercaptopurine (6MP)/methotrexate (MTX) maintenance therapy for acute lymphoblastic leukemia (ALL), possibly indicating a pathogenic role...
9.
Larsen R, Rank C, Grell K, Moller L, Overgaard U, Kampmann P, et al.
Haematologica
. 2021 May;
106(11):2824-2833.
PMID: 34047177
Maintenance therapy containing methotrexate and 6-mercapto - purine is essential to cure acute lymphoblastic leukemia (ALL). Cytotoxicity is elicited by incorporation of thioguanine nucleotides into DNA (DNA-TG), and higher leukocyte...
10.
Nygaard Nielsen S, Toksvang L, Grell K, Nersting J, Abrahamsson J, Lund B, et al.
Cancer Chemother Pharmacol
. 2021 Apr;
88(2):271-279.
PMID: 33928426
Purpose: 6-mercaptopurine(6MP)/methotrexate maintenance therapy is essential to reduce relapse of childhood acute lymphoblastic leukemia (ALL). Common germline variants in TPMT cause low activity of thiopurine methyltransferase (TPMT) and higher 6MP...